ORKA
Oruka Therapeutics
ORKA
ORKA
22 hedge funds and large institutions have $6.09M invested in Oruka Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
12% less funds holding
Funds holding: 25 → 22 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
22
Holding in Top 10
–
Calls
$165K
Puts
$131K
Top Buyers
| 1 | +$120K | |
| 2 | +$90.3K | |
| 3 | +$34.5K | |
| 4 |
Renaissance Technologies
New York
|
+$3.99K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.93K |
Top Sellers
| 1 | -$647K | |
| 2 | -$297K | |
| 3 | -$77.7K | |
| 4 |
Millennium Management
New York
|
-$77K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$57.6K |